Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Senti, Gabriela, Prinz Vavricka, Bettina M., Erdmann, Iris, Diaz, Mella I., Markus, Richard, McCormack, Stephen J., Simard, John J., Wüthrich, Brunello, Crameri, Reto, Graf, Nicole, Johansen, Pål, Kündig, Thomas M.
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: National Academy of Sciences 2008
Pynciau:
Biological Sciences
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/
https://ncbi.nlm.nih.gov/pubmed/19001265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/
https://ncbi.nlm.nih.gov/pubmed/19001265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105

Eitemau Tebyg